cGAS-STING Signalling in the tumour microenvironment: Implications for immune surveillance and therapeutic strategies
International Immunopharmacology · 2026-08 · 182 · 116832
DOI: 10.1016/j.intimp.2026.116832 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-08. Verfasst von Teeb Yasir Mahmoud Al-Adayleh und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplasms, Nucleotidyltransferases, Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 223 Literaturangaben. Gefördert von: Malaysia Ministry of Higher Education, Universiti Sains Malaysia.
Abstract (Originalsprache)
The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway links cytosolic DNA sensing to type I interferon production and inflammatory signalling, making it central to innate immunity. In addition to defending against pathogens, it shapes the tumour microenvironment by regulating immune surveillance, antitumour activity, and tumour progression. Short-term cGAS-STING activation enhances dendritic cell maturation, antigen presentation, macrophage polarisation, and cytotoxic lymphocyte recruitment. However, prolonged activation shifts the TME into an immunosuppressive state by inducing NF-κB-mediated inflammation, expanding regulatory T cells, increasing myeloid-derived suppressor cell accumulation, and elevating immune checkpoint expression. Crosstalk among the STAT3, TGF-β, and autophagy pathways further impacts angiogenesis, fibrosis, and metastasis. Additionally, metabolic stress, mitochondrial DNA (mtDNA) release, and epigenetic silencing of pathway components under hypoxic or chromosomally unstable conditions modify STING responsiveness, ultimately affecting therapeutic outcomes. Pharmacological activation using cyclic dinucleotides (CDN) STING agonists (ADU-S100 and MK-1454) and non-CDN STING agonists (diABZI and MSA-2), as well as MPS1 inhibitors (CFI-402257, BAY-1217389, and CC-671), has effectively triggered strong type I interferon responses and caused tumour regression in preclinical and clinical trials. When combined with radiotherapy, PARP inhibitors, or immune checkpoint blockers, these agents exhibit enhanced synergy but are constrained by tumour heterogeneity and context-dependent toxicity. Here, we reviewed the complexity of the cGAS-STING and its potential as a double-edged sword in cancer treatment, underscoring the need for strict strategies to harness this pathway while enhancing antitumour immunity and mitigating pro-tumorigenic effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia.
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia; Centre for Drug Research, Universiti Sains Malaysia, Penang 11800, Malaysia.
- Department of Biomedical Science, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200 Bertam, Kepala Batas, Penang, Malaysia; Breast Cancer Translational Research Program, BCTRP@IPPT, Advanced Medica…
- Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, 31982 Al Ahsa, Saudi Arabia.
- School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia. Electronic address: aliattiq@usm.my.
Förderung
- Malaysia Ministry of Higher Education
- Universiti Sains Malaysia
Zitieren
APA
Al-Adayleh, T. Y. M., Ahmad, W., Rahiman, S. S. F., Murugaiyah, V., Mohamed, R., Afzal, S., Al-Ramamneh, R. S., & Attiq, A. (2026). cGAS-STING Signalling in the tumour microenvironment: Implications for immune surveillance and therapeutic strategies. International Immunopharmacology, 182, 116832. https://doi.org/10.1016/j.intimp.2026.116832
Vancouver
Al-Adayleh TYM, Ahmad W, Rahiman SSF, Murugaiyah V, Mohamed R, Afzal S, et al. cGAS-STING Signalling in the tumour microenvironment: Implications for immune surveillance and therapeutic strategies. International Immunopharmacology. 2026;182:116832. doi:10.1016/j.intimp.2026.116832
BibTeX
@article{AlAdayleh2026,
author = {Al-Adayleh, Teeb Yasir Mahmoud and Ahmad, Waqas and Rahiman, Siti Sarah Fazalul and Murugaiyah, Vikneswaran and Mohamed, Rafeezul and Afzal, Sheryar and Al-Ramamneh, Rahmeh Saad and Attiq, Ali},
title = {cGAS-STING Signalling in the tumour microenvironment: Implications for immune surveillance and therapeutic strategies},
journal = {International Immunopharmacology},
year = {2026},
volume = {182},
pages = {116832},
doi = {10.1016/j.intimp.2026.116832}
}
EUVIMED